Jennison Associates LLC grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,848 shares of the company’s stock after purchasing an additional 4,949 shares during the period. Jennison Associates LLC’s holdings in […]
abrdn plc bought a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 154,269 shares of the company’s stock, valued at approximately $4,704,000. abrdn plc owned about 0.17% of Intellia Therapeutics as […]
Wedbush reiterated their neutral rating on shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $29.00 target price on the stock. A number of other equities research analysts also recently weighed in on NTLA. Wolfe Research assumed coverage on Intellia Therapeutics in a […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price […]
Chevy Chase Trust Holdings LLC decreased its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 991,175 shares of the company’s stock after selling 11,780 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Intellia Therapeutics were worth $30,221,000 at the […]